0000902664-20-001237.txt : 20200219
0000902664-20-001237.hdr.sgml : 20200219
20200219144559
ACCESSION NUMBER: 0000902664-20-001237
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200214
FILED AS OF DATE: 20200219
DATE AS OF CHANGE: 20200219
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: CLEMENS PETER J IV
CENTRAL INDEX KEY: 0001199421
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-09974
FILM NUMBER: 20629042
MAIL ADDRESS:
STREET 1: 2383 N. BERRY'S CHAPEL RD.
CITY: FRANKLIN
STATE: TN
ZIP: 37069
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ENZO BIOCHEM INC
CENTRAL INDEX KEY: 0000316253
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071]
IRS NUMBER: 132866202
STATE OF INCORPORATION: NY
FISCAL YEAR END: 0731
BUSINESS ADDRESS:
STREET 1: 60 EXECUTIVE BLVD
CITY: FARMINGDALE
STATE: NY
ZIP: 11735
BUSINESS PHONE: 5167555500
MAIL ADDRESS:
STREET 1: ENZO BIOCHEM INC
STREET 2: 60 EXECUTIVE BLVD
CITY: FARMINGDALE
STATE: NY
ZIP: 11735
4
1
ownership.xml
X0306
4
2020-02-14
0
0000316253
ENZO BIOCHEM INC
ENZ
0001199421
CLEMENS PETER J IV
2383 N. BERRY'S CHAPEL RD.
FRANKLIN
TN
37069
0
0
1
0
Common Stock, $0.01 par value ("Common Stock")
2020-02-14
4
P
0
6000
2.21
A
11000
D
Common Stock
2020-02-18
4
P
0
4000
2.20
A
15000
D
This Form 4 is filed by Peter J. Clemens, IV (the "Reporting Person"). The Reporting Person may be deemed to be a member of a Section 13(d) group that collectively beneficially owns more than 10% of the Issuer's outstanding common stock. The Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of his pecuniary interest therein.
/s/ Peter J. Clemens, IV
2020-02-19